CDT logo

CDT EQUITY INC

CDTNASDAQ
🏆 #5529 by market capUS Equity
$1.55▼ $0.29 (−18.42%)
Live
🔔
Track CDT
Get earnings, price moves & breaking news on Telegram
Track
24h▼ 18.4%
7d▼ 56.3%
14d▼ 70.4%
30d▼ 96.3%
ytd▼ 100.0%
1y▼ 100.0%
🏦Market Cap
$753,033
Small Cap
📈Revenue Growth (YoY)
+0.0%
Slowing
📊Gross Margin
38.6%
Healthy
💵FCF Margin
-0.1%
Thin
⚖️P/S Ratio
0.0x
Cheap
Otter Score
52
Weak

Trading Snapshot

Day Range
$1.53 – $1.57
52-Week Range
$0.07 – $1,778.00
Volume
$5.02B
Avg Volume
$5.90B
Shares Outstanding
485,828
Next Earnings
Nov 15, 2026

Fundamentals Snapshot

Annual Revenue
$1.45B
Last Q Revenue
$750M
P/E Ratio
0.0
P/S Ratio
0.0x
EPS (TTM)
$2.34
Dividend Yield
0.00%
Dilution (1yr)
+19861.0%

Why Investors Own CDT

  • ✓High-growth profile — revenue up +39.7% YoY with expanding US Equity exposure.
  • ✓Healthy economics — 29% gross margin and 19% free-cash-flow margin.
  • ✓New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

CDT logo

CDT EQUITY INC

CDT
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$0▲ +0.0% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
−$37M▲ +138.4% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
−$18M▲ +84.5% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
921K▲ +19861.0% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
−$896M▼ −$889M YoY
StockOtter · stockotter.space

About CDT EQUITY INC

Based in Naples, Florida, CDT Equity, Inc. commenced operations in October 2021. This firm, co-founded by David Joszef Tapolczay and Freda C. Lewis-Hall, focuses on aiding the advancement and market entry of clinical-stage medical innovations.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)
💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
💧Dilution★★★★★
Overall Score
Weak
52/100

Analyst Price Target

ⓘ
Average Target
$1.64
▲ +5.9% Upside
High Target$1.83
Low Target$1.49
Based on 15 analysts

Latest News & Updates

GlobeNewsWire·9h ago

CDT Highlights Sarborg's Expanding Quantum Computing IP Portfolio and Application to Drug Discovery

NAPLES, Fla. and CAMBRIDGE, United Kingdom, Sept.

GlobeNewsWire·4d ago

CDT Equity Inc. Announces Reverse Stock Split

NAPLES, Fla. and CAMBRIDGE, United Kingdom, Sept. 25, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”), announces that its board of directors has approved a 1-for-25 reverse stock split of

GlobeNewsWire·11d ago

CDT Partners with QIMA Life Sciences to Evaluate Novel Tapinarof Combinations in Psoriasis and Vitiligo

NAPLES, Fla. and CAMBRIDGE, United Kingdom, Sept.

GlobeNewsWire·19d ago

CDT Highlights Sarborg's Application of Signature Intelligence and Quantum Computing Models to Mental Health

NAPLES, Fla. and CAMBRIDGE, United Kingdom, Sept.

GlobeNewsWire·27d ago

CDT Provides Capital Update and Confirms No Nasdaq Deficiencies

NAPLES, Fla. and CAMBRIDGE, United Kingdom, Sept.

GlobeNewsWire·28d ago

CDT Appoints Co-Founder James Bligh as Chief Executive Officer to Lead Next Phase of Growth

NAPLES, Fla. and CAMBRIDGE, United Kingdom, Sept.